Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes.
Chinmay S MaratheLaurence G TrahairTanya J LittleMichelle J BoundXiang ZhangHang WuZilin SunMichael HorowitzChristopher K RaynerKaren L JonesPublished in: Diabetes care (2017)
Vildagliptin reduces BP and increases HR, whereas metformin increases HR without affecting BP during ID glucose infusion in type 2 diabetes. These distinct cardiovascular profiles during enteral nutrient exposure may have implications for postprandial hypotension.